Bart van Hoek

15.1k citations
215 papers · 5.5k indexed · 1 hit paper · h-index 37

Impact in

  • Hepatology top 0.1%
    • Liver Disease and Transplantation
    • Liver Diseases and Immunity
    • Renal Transplantation Outcomes and Treatments

Papers in

    • Liver Disease and Transplantation 102
    • Liver Diseases and Immunity 31
    • Hepatitis C virus research 18
    • Renal Transplantation Outcomes and Treatments 33

Bart van Hoek

208 papers receiving 5.3k citations

Hit Papers

Population-based epidemiology, malignancy risk, and outcome of primary sclerosing cholangitis 2013 · 472 citations
4722013202620172021100200300400

Peers

Bart van Hoek
Comparison fields: 5 of 141
  • Hepatology 3.6k
  • Transplantation 526
  • Epidemiology 2.4k
  • Surgery 2.4k
  • Internal Medicine 89
Replace Carl L. Berg with:
Carl L. Berg United States
Yuji Soejima Japan
Charles M. Miller United States
Darius F. Mirza United Kingdom
Paul D. Greig Canada
Olivier Farges France
Seiji Kawasaki Japan
Steven M. Strasberg United States
Kyung‐Suk Suh South Korea
Alan G. Jardine United Kingdom
Bart van Hoek relative to Carl L. Berg United States Carl L. Berg's profile →
Citations per field
00.5×2.6×
Carl L. Berg · 1×
Citations per year

Countries citing papers authored by Bart van Hoek

Since Specialization
Citations

This map shows the geographic impact of Bart van Hoek's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bart van Hoek with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bart van Hoek more than expected).

Fields of papers citing papers by Bart van Hoek

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bart van Hoek. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bart van Hoek. The network helps show where Bart van Hoek may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Bart van Hoek, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Bart van Hoek Line = papers co-authored together Bart van Hoek links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20243
2 20230
3 20233
4 20233
5 20235
6 20235
7 202222
8 20224
9 20216
10 202014
11 20208
12 201945
13 201966
14
['Will I receive a liver transplant in time?'; chance of survival of patients on the liver transplant waiting list].
20181
15 20189
16 20151
17
The 2012 revised Dutch national guidelines for the treatment of chronic hepatitis B virus infection.
20127
18 201175
19
The potentiating effect of ribavirin on interferon in the treatment of hepatitis C: lack of evidence for ribavirin-induced viral mutagenesis.
200316
20
Indicators of survival in patients with portal vein thrombosis.
19990

About Bart van Hoek

Bart van Hoek is a scholar working on Hepatology, Transplantation, Epidemiology, Surgery and Hematology, having authored 215 papers that have together received 5.5k indexed citations. Recurring topics across this work include Liver Disease and Transplantation (102 papers), Organ Transplantation Techniques and Outcomes (86 papers), Liver Disease Diagnosis and Treatment (80 papers), Renal Transplantation Outcomes and Treatments (33 papers), Liver Diseases and Immunity (31 papers), Hepatitis C virus research (18 papers), Hepatitis B Virus Studies (15 papers) and Pediatric Hepatobiliary Diseases and Treatments (12 papers). The work is most often cited by research in Hepatology (3.6k citations), Transplantation (526 citations), Epidemiology (2.4k citations), Surgery (2.4k citations) and Internal Medicine (89 citations). Bart van Hoek has collaborated with scholars based in Netherlands, United States and Belgium. Frequent co-authors include Russell H. Wiesner, Karel J. van Erpecum, Joost P.H. Drenth, Hein W. Verspaget, J.P. van der Eerden, Harry L.A. Janssen, P. Bennema, Robert J. Porte, Jan Ringers and Henk R. van Buuren. Their work appears in journals such as Journal of Hepatology, Liver Transplantation, Journal of Crystal Growth, Liver International and Hepatology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026